Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B

Chronic hepatitis B virus (HBV) is a serious and life-threatening disease afflicting 350 million of the world’s population. So far, current monotherapy with conventional interferon-alpha, lamivudine, and adefovir dipivoxil remains unsatisfactory. In addition, the use of conventional interferon-alpha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Lawrence, Hui, Chee-Kin, Leung, Nancy, Lau, George K
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426802/
https://www.ncbi.nlm.nih.gov/pubmed/17717966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426802/
https://www.ncbi.nlm.nih.gov/pubmed/17717966

Ejemplares similares